P olymorphonuclear leukocytes (PMN)
3 are the first bloodborne nucleated cells to populate a site of acute inflammation. PMN isolated from the blood are normally shortlived and undergo spontaneous apoptosis upon in vitro culture (1, 2) . However, entry into an inflammatory locus extends PMN lifespan (3) (4) (5) (6) (7) . In this regard, work from this laboratory demonstrated that Ͼ90% PMN harvested within 24 h after injury from sterile experimental wounds in rats survive overnight incubation in vitro (8) . In contrast, ϳ60% of circulating PMN and those retrieved from the wounds 2-3 days after wounding are apoptotic by the end of identical cultures (8) . Thus, while early inflammatory PMN have a survival advantage over their circulating counterparts, PMN longevity appears to be reduced as the wound progresses. The current paradigm indicates that infiltrating PMN undergo spontaneous apoptosis at the site of inflammation, where they are subsequently recognized and ingested by neighboring macrophages (M) (reviewed in Ref. 9) . In support of this paradigm, M isolated from the aforementioned wounds, where the disappearance of PMN coincides temporally with the establishment of a M-dominant infiltrate, were able to ingest apoptotic, but not viable, wound PMN (8) .
Apoptosis of inflammatory PMN and their clearance by M has been interpreted as beneficial because the recognition and ingestion of apoptotic PMN, or of their shed apoptotic bodies, prevents the lytic release of potentially noxious contents into the microenvironment (10) . In addition, it has been proposed that the ingestion of apoptotic PMN triggers the production of antiinflammatory mediators by the M (11, 12) . Moreover, persistent PMN-rich inflammatory infiltrates have been associated with the increased tissue destruction associated with unresolved inflammatory reactions, such as those found in adult respiratory distress syndrome, rheumatoid arthritis, and gout (reviewed in Refs. 13 and 14) . It appears, then, that efficient PMN removal is required for the resolution of acute inflammation and probably for the progression of wound healing.
Experiments reported here tested the hypothesis that, beyond ingesting already apoptotic PMN, M can actively induce apoptosis of PMN. Results to be presented, obtained using an experimental wound model in rats, support this hypothesis and demonstrate that the capacity to induce apoptosis in wound PMN is restricted to M isolated from the wound. In contrast with other models where PMN apoptosis is induced by M secretory products (15) (16) (17) (18) (19) , findings indicate that the induction of PMN apoptosis by wound M requires cell-to-cell contact and the constitutive presentation on M effectors of ␤ 3 integrin subunits, CD36, and membranebound, but not soluble, TNF-␣. Further confirming evidence was provided by transfection of ␣ v ␤ 3 integrin and an uncleavable form of membrane-bound TNF-␣ (mTNFdm) into otherwise noncytotoxic cells, which endowed them with the ability to induce wound PMN apoptosis.
Where indicated, M in day 2 and 5 wound cell preparations were enriched by adherence to plastic. Cell counts were performed on LeukoStat-stained (Fisher Scientific, Pittsburgh, PA) cytospins (Shandon, Pittsburgh, PA).
Resident-and Propionibacterium acnes-elicited peritoneal M were collected as previously described (8) . The human chronic myelogenous leukemia cell line, K562 (American Type Culture Collection, Manassas, VA), was maintained in RPMI 1640 (Life Technologies, Grand Island, NY), 10% FBS (HyClone, Logan, UT), 2 mM glutamine, 100 U/ml penicillin-streptomycin and propagated at 37°C in a 7% CO 2 in air humidified incubator. K562 cells stably transfected with ␣ v ␤ 3 integrin subunits were generously provided by Eric Brown (University of California, San Francisco, CA) (21) and maintained in media containing 1.2 mg/ml G418 (Sigma, St. Louis, MO). Expression of ␣ v ␤ 3 was confirmed by flow cytometry.
In coculture experiments, 1 ϫ 10 6 cells from 2-or 5-day-old wounds, peritoneal M, or K562 cells were coincubated with 2 ϫ 10 5 cells isolated from 1-day-old wounds in RPMI 1640, 1% FBS, 10 mM MOPS, 5 ϫ 10 Ϫ5 M 2-ME, and 100 U/ml penicillin-streptomycin for 24 h at 37°C in 7% CO 2 in air. Control cultures contained day 1 wound cells. In additional coculture experiments, day 5 wound cells were separated from day 1 wound cells in 0.2 M transwell 24-well plates (Costar, Cambridge, MA). Day 5 wound cells were also fixed (1% paraformaldehyde, 1 h at room temperature) and washed with PBS before coculture with day 1 wound cells at a 5:1 ratio. Membranes from 10 6 viable day 5 wound cells were isolated as previously described (22) and used similarly in cocultures.
Where indicated, day 5 wound cells were treated with 1 mM peptide Arg-Gly-Asp-Ser (RGDS) (Sigma, 20 min, 37°C), 25 g/ml anti-rat CD61 (␤ 3 chain) mAb (PharMingen, San Diego, CA), or 25 g/ml anti-rat TNF-␣ polyclonal Ab (Endogen, Woburn, PA) before exposure to day 1 wound cells. Additionally, day 1 wound cells were treated with 25 g/ml anti-rat TNFR-I (p55) or -II (p75) polyclonal Ab (Santa Cruz Biotechnology, Santa Cruz, CA) before exposure to day 5 wound cells. Ab treatments were for 1 h at 4°C. Control cells were treated with 1 mM peptide Arg-Gly-Glu-Ser (RGES) (Sigma), 25 g/ml species-matched nonspecific IgG control Ab (Jackson ImmunoResearch, West Grove, PA), or left untreated. Day 5 and 1 wound cells were also cocultured in the presence of 20 g/ml CD36 peptide (p93-110) (American Peptide Company, Sunnyvale, CA). In addition, day 1 wound cells were treated for 24 h with 10 -100 ng/ml rat rTNF-␣ (Biosource International, Camarillo, CA) alone or in cocultures containing K562 cells transfected with ␣ v ␤ 3 .
Where indicated, K562 cells were treated with 25 g/ml anti-human-␤ 3 (AP-3) polyclonal Ab (American Type Culture Collection), 25 g/ml antihuman CD36 mAb (Ab-3) (NeoMarkers, Union City, CA), or 25 g/ml anti-mouse TNF-␣ polyclonal Ab (Biosource International) for 1 h at room temperature before exposure to day 1 wound cells. Control K562 cells were treated with 25 g/ml species-matched nonspecific IgG control Ab (Jackson ImmunoResearch) or left untreated.
Assessment of apoptosis
PMN (Ն300) were evaluated for apoptosis through morphological characterization on LeukoStat-stained cytospins using bright field microscopy. Criteria used to diagnose apoptosis included chromatin aggregation, cytoplasmic vacuolation, and/or cell shrinkage (2) . Results obtained by morphological exam were directly compared with those from flow cytometry with propidium iodide analysis of DNA content (23) . Results obtained with either method were not different (i.e., PMN apoptosis in cultured day 1 wound cells ϭ 5.4 Ϯ 1.9% by morphology vs 6.6 Ϯ 1.4% by propidium iodide, p Ͼ 0.05, 2 ; PMN apoptosis in day 5 wound cells cocultured with day 1 wound cells ϭ 17.9 Ϯ 0.8% by morphology vs 20.1 Ϯ 4.2% by propidium iodide, p Ͼ 0.05, 2 ). Data shown are from morphological examination. Results reported in Figs. 1 and 2 are total apoptotic PMN at the end of culture. Thereafter, results are expressed as induced apoptosis (%), which equals apoptosis in cocultures minus apoptosis in day 1 wound cells cultured alone.
Cell transfection
SalI-flanked cDNA was isolated from pSV23SmTNFd1-9K11E (LMBP 3404) (Belgian coordinated collections of microorganisms/Laboratorium voor Moleculaire Biologie-Plasmiden-collectie, Gent, Belgium). This cDNA (mTNFdm) encodes a deletion (the first 9 aa of the mature sequence), mutant (Lys to Glu substitution of amino acid 11) of the 26-kDa form of TNF-␣ that expresses an uncleavable, membrane-bound form of TNF-␣ (24). The mTNFdm insert was subcloned into the pcDNA3.1 ϩ hygro (Invitrogen, San Diego, CA) expression vector at the multicloning XhoI site and transformed (25) into DH5␣-FЈ Escherichia coli (American Type Culture Collection). Transformation products were screened initially by PCR using synthesized T7 and BGH primer pairs (Genosys, The Woodlands, TX) as per Invitrogen's sequence specifications. Proper orientation of the insert was confirmed by restriction enzyme mapping using SpeI and DNA sequencing (Yale University, New Haven, CT). K562 cells were cotransfected with mTNFdm and pEYFP-N1 plasmid for yellow-green fluorescence protein (Clontech, San Francisco, CA) by electroporation at 220 V, 1000 F using a Gene Pulsar II (Bio-Rad, Richmond, VA). Populations of transfectants expressing green fluorescence protein were purified to Ͼ90% positive by fluorescence cell sorting on a FACScan (Becton Dickinson, Franklin Lakes, NJ). Control K562 cells were cotransfected with pcDNA3.1 vector backbone and pEYFP-N1.
Analysis of protein expression
Expression of ␤ 3 integrin subunit was analyzed by fluorescent flow cytometry as previously described (26) using anti-human ␤ 3 (AP-3) polyclonal Ab (American Type Culture Collection) or species-matched nonspecific IgG control Ab (Jackson ImmunoResearch) and quantified by mean channel fluorescence.
Expression of mTNFdm protein after transfection of wild-type K562 cells and K562 cells stably transfected with ␣ v ␤ 3 was analyzed by immunofluorescence. Transfected K562 cells were fixed in 4% paraformaldehyde in PBS for 30 min at room temperature, cytospun onto glass slides, and stained. Fixed K562 cells cytospins were blocked with 10% normal goat serum for 30 min at room temperature and then stained with either 1 g/ml anti-mouse TNF-␣ polyclonal Ab (Biosource International), 1 g/ml anti-human TNF-␣ polyclonal Ab (R&D Systems, Minneapolis, MN), or 1 g/ml mouse (Sigma) or rabbit (Jackson ImmunoResearch) IgG isotype controls for 1 h at room temperature. Slides were washed and incubated with 1 g/ml Texas Red-conjugated goat F(abЈ) 2 anti-rabbit IgG (Accurate, Westbury, NY) for 30 min.
Positive cells were quantified using a Nikon Microphot-FXA (Microvideo Instruments, Avon, MA), images were captured using a SenSys CCD fitted with PVCAM acquisition software (Photometrics, Tucson, AZ), and integrated OD per cell (IOD) was determined for 40 cells using NIH 
Data presentation and analysis
Experiments were repeated at least twice. Throughout the manuscript, n represents the number of independent experiments each including at least triplicate samples. Unless otherwise stated, data are means Ϯ SD from triplicate samples from a representative experiment. Statistical analysis was performed as indicated in the text.
Results and Discussion

PMN apoptosis in cultured day 1 wound cells correlates with the number of M
Comparable to previous results (8), 87.4 Ϯ 3.4% of the cells retrieved from 1-day-old wounds were PMN, with Յ3% of the PMN being apoptotic upon harvest (8) . M represented 4 -21% of the remaining cells. The frequency of apoptotic PMN in the preparations after 24 h in culture ranged between 2 and 16% (n ϭ 58) and correlated linearly with the number of M present ( p Ͻ 0.05, r 2 ϭ 0.91) (Fig. 1) .
Coculture of day 1 and day 5 wound cells increases PMN apoptosis
The strong correlation between the frequency of PMN apoptosis in cultured day 1 wound cells and the number of M present suggested the hypothesis that PMN apoptosis could be actively induced by M. To test this hypothesis, day 1 wound cell preparations were exposed to excess M in coculture experiments (n ϭ 24) where day 5 wound cells (90.2 Ϯ 2.6% M, 6.0 Ϯ 2.2% PMN) were added at a 5:1 ratio to day 1 wound cells and incubated for 24 h. The frequency of apoptotic PMN by the end of culture (18.0 Ϯ 0.8%) was higher than in cultures of day 1 wound cells alone (6.2 Ϯ 0.5%, p Ͻ 0.05, Student's t test) (Fig. 2) . Similar As mentioned above, unpurified day 5 wound cell preparations used as effectors contained ϳ6.0% PMN. These cells did not account for the excess PMN apoptosis observed in cocultures. This conclusion is supported by findings in cocultures of day 1 wound cells with adherence-purified M, fixed day 5 wound cells, or isolated cell membranes (see below) where PMN apoptosis was the same as in cocultures with unpurified day 5 wound cells.
The frequency of PMN apoptosis determined at the end of culture probably underestimates its actual rate because PMN undergoing apoptosis during the overnight coculture are likely to be rapidly ingested by M (10) . In this regard, 3-6% of M contained myeloperoxidase-positive vacuoles by the end of culture.
The ability to induce PMN apoptosis was not restricted to M from 5-day-old wounds because adherence-purified M from 2-day-old wounds (Ն95% M) were equally competent in inducing PMN apoptosis (induced apoptosis ϭ 13.4 Ϯ 1.6% for day 2 wound M cocultured with day 1 wound cells at a 5:1 ratio). In contrast, resident-and P. acnes-elicited peritoneal M, which were previously shown to recognize and ingest apoptotic wound PMN (8), were incapable of inducing PMN apoptosis (induced apoptosis ϭ Ϫ1.1 Ϯ 1.6% and Ϫ0.4 Ϯ 0.7%, respectively).
Recent work from this laboratory demonstrated that inducible NO synthase is expressed exclusively by M in day 1 wound cell preparations (27) . Because NO is known to induce apoptosis in target cells (28) , its potential role in M-dependent PMN apoptosis was investigated. Wound PMN proved to be remarkably resistant to NO. Culture of these cells for 24 h with NO donors in concentrations shown in this laboratory to kill different cell lines (S-nitroso-N-acetyl-D,L-penicillamine up to 200 M, and 3-morpholinosydnonimine up to 100 M) did not induce PMN apoptosis. Moreover, day 5 adherence-purified wound M treated with the inducible NO synthase inhibitor, N G -monomethyl-L-arginine (500 M), were as capable of inducing PMN apoptosis as untreated M (data not shown).
Induction of PMN apoptosis by M requires cell-to-cell contact
The induction of PMN apoptosis by M was determined to be mediated by constitutive effectors on the M membrane. In this regard, data in Fig. 3 demonstrate that: 1) separating day 5 and day 1 wound cells in a transwell culture system prevents PMN apoptosis; 2) addition of culture supernatants from day 5 adherencepurified wound M at 50% v:v to day 1 wound cells failed to induce PMN apoptosis; 3) fixed day 5 wound cells and cell membrane fractions from day 5 wound cells were as competent as live cells in inducing PMN apoptosis.
M induction of PMN apoptosis requires M expression of ␤ 3 integrin and CD36
The current paradigm indicates that the ingestion of apoptotic PMN by M requires intercellular binding where a M ␣ v ␤ 3 integrin/CD36 complex binds to extracellular thrombospondin, which in turn acts as a "bridge" to PMN thrombospondin receptors (reviewed in Ref. 29) . Indeed, previous work in this laboratory demonstrated that phagocytosis of apoptotic wound PMN by wound M was partially inhibitable by the integrin-binding site peptide RGDS (8) . As shown in Fig. 4 , pretreatment of day 5 wound cells with RGDS (Fig. 4A) or with an anti-rat ␤ 3 Ab (Fig.  4B ) suppressed M induction of PMN apoptosis. Integrin involvement was restricted to the M because treatment of day 1 wound cells with RGDS before coculture did not alter induction of PMN apoptosis (data not shown). Moreover, addition to cocultures of a synthetic partial CD36 peptide known to block CD36 binding to thrombospondin (30) also reduced M induction of PMN apoptosis (Fig. 4C) .
Integrin-ligand interactions may explain the "tethering" of viable PMN to M reported by this laboratory (8) and by others (31) but are unlikely to mediate the induction of PMN apoptosis. While engagement of ␤ 2 integrins has been shown to trigger PMN apoptosis (32), a similar capacity has not been reported for ␤ 3 subunits. Present results and those by others (33) demonstrate that integrin presentation in M-to-PMN binding occurs on the effector M and not on the PMN target.
Membrane-bound TNF-␣ mediates M induction of PMN apoptosis
Based on reports of the susceptibility of blood PMN to TNF-␣ (18), experiments were conducted to examine the potential role of this cytokine as the effector of M-induced PMN apoptosis. Pretreatment of day 5 wound cells with Ab directed against rat TNF-␣ markedly reduced the ability of wound M to induce PMN apoptosis in cocultures (Fig. 5) . Similar results were obtained when paraformaldehyde-fixed day 5 wound cells were pretreated with anti-TNF-␣ Ab (induced apoptosis ϭ 10.6 Ϯ 1.4% for anti-TNF Ϫ vs 4.9 Ϯ 1.2% for anti-TNF ϩ , p Ͻ 0.05, Student's t test). Interestingly, day 1 wound PMN tolerated overnight treatment with soluble rat rTNF-␣ up to 100 ng/ml (5.1 Ϯ 0.7% PMN apoptosis in day 1 wound cells alone vs 5.0 Ϯ 0.6% in day 1 wound cells with 100 ng/ml rTNF-␣). This observation agrees with reports by others that, unlike blood PMN, inflammatory PMN do not undergo apoptosis in response to soluble TNF-␣ (19) .
The absolute requirement for cell-to-cell contact in the induction of PMN apoptosis by M, the suppressive effects of the anti-TNF-␣ Ab, and the ineffectiveness of soluble TNF-␣ suggested that the membrane-bound form of TNF-␣ was cytotoxic to the PMN. In this regard, TNF-␣ is synthesized as an integral transmembrane 26-kDa protein that is cleaved to generate a 17-kDa soluble secretory component (34) . The membrane-bound form of TNF-␣ is known to mediate tumor cell killing (35-37) inclusive of some target cells known to resist soluble TNF-␣ (38) .
To further investigate the requirement for membrane-bound vs soluble TNF-␣ in the induction of PMN apoptosis, day 5 wound cells were treated with anti-TNF-␣ Ab and cocultured with day 1 wound cells in the presence of excess soluble rTNF-␣ (100 ng/ml).
M-induced PMN apoptosis was not reestablished by this treatment (induced apoptosis ϭ 9.8 Ϯ 1.4% for wound M; 0.8 Ϯ 0.7% for anti-TNF-␣-pretreated wound M; 1.2 Ϯ 1.0% for anti-TNF-␣-pretreated wound M plus rTNF-␣).
Pretreatment of day 1 wound cells with Ab directed against rat TNFR-I decreased the capacity of day 5 wound cells to induce PMN apoptosis in cocultures by 41% (induced apoptosis ϭ 14.6 Ϯ 1.9% for species-matched nonspecific IgG-treated cells vs 6.9 Ϯ 1.3% for anti-TNFR-I-pretreated day 1 wound cells, p Ͻ 0.05, Student's t test). While TNFR-I is thought to be the main mediator of cellular responses to soluble TNF-␣ (39), engagement of both TNFR-I and -II has been shown to be involved in blood PMN apoptosis (18) . Moreover, Grell et al. (39) demonstrated that membrane-bound TNF-␣ cooperatively signals through both receptors. 
Gene transfer of ␣ v ␤ 3 and membrane-bound TNF-␣ endow noncytotoxic effectors with the ability to induce PMN apoptosis
Results shown so far confirmed roles for M ␤ 3 , CD36, and membrane-bound TNF-␣ in mediating PMN apoptosis. However, they did not exclude Fas ligand (FasL) as a component of the effector mechanism. Indeed, the Fas (CD95)-FasL system has been reported to induce PMN apoptosis in vitro (16, 40) . Because Abs capable of neutralizing rat FasL are not available, an alternative approach was taken to investigate both the potential involvement of this effector molecule and to further dissect the roles of ␤ 3 , CD36, and membrane-bound TNF-␣ in the induction of wound PMN apoptosis by wound M. For this purpose, the ␤ 3 -negative, FasL-negative, TNF-␣-negative, and CD36-positive (41-44) K562 cell line was used in subsequent experiments. Coculture of wild-type K562 cells with day 1 wound cells did not increase PMN apoptosis (induced apoptosis ϭ 0.3 Ϯ 0.2%, mean Ϯ SEM, n ϭ 8).
To more precisely define the role of ␤ 3 integrin in the induction of PMN apoptosis, stable ␣ v ␤ 3 K562 cell transfectants (21) (Fig. 7) .
It has been proposed that ␣ v ␤ 3 and CD36 cooperatively bind thrombospondin, which in turn tethers apoptotic PMN to M before their phagocytic removal (45) . However, pretreatment of double K562 cell transfectants (TNF-␣ ϩ /␤ 3 ϩ ) with anti-CD36 blocking Ab (46) did not suppress the induction of PMN apoptosis (induced apoptosis ϭ 18.0 Ϯ 1.3% for TNF-␣ ϩ /␤ 3 ϩ K562 cells vs 18.0 Ϯ 2.0% for TNF-␣ ϩ /␤ 3 ϩ K562 cells pretreated with CD36 Ab). These data contrast findings with day 1 and day 5 wound cell cocultures where a partial CD36 peptide reduced PMN apoptosis by 47.2 Ϯ 8.5%. The dramatic overexpression of ␤ 3 in the transfected cells (mean channel fluorescence with anti-␤ 3 Ab staining, wild-type K562 cells ϭ 8.9 vs K562 cells stably transfected with ␤ 3 integrin ϭ 827.6) may provide sufficient anchoring for thrombospondin to allow PMN tethering to effector cells regardless of the availability of CD36.
As mentioned in the Introduction, the current paradigm in regard to the resolution of acute inflammation indicates that PMN undergo spontaneous apoptosis and are then engaged and engulfed by M. Previous work from this and other laboratories indicate that the putative M integrin-thrombospondin-PMN extracellular matrix receptor complex is relevant to the recognition and phagocytic disposal of apoptotic PMN by M (8, 33, 45) . This mechanism may serve simply to intimately associate PMN with M and lead to phagocytosis if the PMN is apoptotic or to PMN demise through membrane-bound TNF-␣ if viable. Alternatively, engagement of the recognition complex may trigger intracellular signaling in either or both cell types. Results with fixed M and with M membranes rule out intracellular signaling at the M level. In regard to the PMN, current results allow the conclusion that the association of viable PMN with M through RGDS-or anti-␤ 3 -inhibitable means is not sufficient to trigger their apoptosis. Moreover, as shown for both M and ␣ v ␤ 3 -positive K562 cells transfectants, the availability of the binding mechanism does not sensitize the cells to soluble-TNF-␣.
The resistance of early PMN to soluble TNF-␣ and their sensitivity to the membrane-bound form of this cytokine in the context of the wound microenvironment is worthy of comment. Extracellular fluid obtained from the wounds contains ϳ2400 U/ml and 600 U/ml soluble TNF-␣ 12 and 24 h postinjury, respectively (activity represents ϳ12 and 3 ng/ml of bioactive TNF-␣, respectively) (our unpublished observations). In contrast, day 5 wound M contain 2.7 Ϯ 0.4 U TNF-␣/10 6 (data not shown). The differential sensitivity of PMN to soluble vs membrane-bound TNF-␣ together with the requirement for integrin-mediated association of PMN to M may serve to assure that PMN survive in the hostile environment of the wound and only undergo apoptosis when specifically instructed by the M.
Findings presented here extend the current model explaining the disappearance of PMN from an inflammatory site by demonstrating that wound M, but not other M populations, can use an integrin-and membrane-bound TNF-␣-dependent effector mechanism to actively induce PMN apoptotic death. The relative quantitative contribution of spontaneous vs M-induced PMN apoptosis to the resolution of the neutrophilic infiltrate of wounds and other sites of sterile inflammation remains to be determined. 
